期刊文献+

高血压患者的载脂蛋白AⅠ B分析

Analysis of apolipoprotein AⅠand B in hypertensive patients
下载PDF
导出
摘要 目的 :调查高血压患者的载脂蛋白 A 、B水平。 方法 :用国产载脂蛋白 apo A 、B免疫比浊试剂盒和经WHO- IFCC国际参考材料靶值转移后的标准品 ,在全自动分析仪上调查 2 2 3例高血压患者、42 0例健康老年人和12 5 1例健康人的血脂、脂蛋白、载脂蛋白 (apo A 、B)。 结果 :高血压组载脂蛋白水平 apo A 为 (1.38± 0 .2 5 ) g/L、apo B为 (1.0 1± 0 .2 2 ) g/ L。经 t检验分析 ,高血压组的 BMI、PB、TG、HDL、apo A 、B与对照组 2差异显著 (P<0 .0 5 ) ,而 TC和 L DL- C差异不明显。 结论 :高血压患者的血脂、脂蛋白和载脂蛋白存在异常 ,要引起人们足够重视。 Objectives:To study serum apolipoprotein (apo)AⅠand apo B levels in patients with hypertension. Methods:Using apolipoprotein (apo)AⅠand B target values from WHO IFCC reference materials to study serum lipids, lipoprotein and apolipoprotein (aplAⅠ,B) levels in 223 hypertensive patents,420 aged subjects and 1251 healthy subjects. Results:The average apo AⅠand apo B levels in hypertension group were (1.38±0.25)g/L and (1.01±0.22)g/L respectively. Levels of BMI,PB,TG,HDL C,apo AⅠand apo B were different significantly in hypertensive group comparing with healthy group( P <0.05) while the levels of TC and LDL C were not significantly different between the two groups. Conclusions:Levels of lipids, lipoprotein and apolipoprotein were abnormal in patients with hypertension, to which attention should be paid.
作者 李勇 庄一义
出处 《医学研究生学报》 CAS 2001年第z1期40-42,共3页 Journal of Medical Postgraduates
关键词 高血压病 载脂蛋白AⅠ、B 血脂 脂蛋白 Hypertension Apolipoprotein AⅠ,B Lipids lipoproteins
  • 相关文献

参考文献13

  • 1庄一义,李勇,陈铭生,陆美珍,王小明,刘中令,凌翔.国际载脂蛋白 A1、B 参考材料靶值的转移[J].临床检验杂志,1997,15(3):135-138. 被引量:17
  • 2李勇,庄一义.血清载脂蛋白A1和B参考值调查[J].临床检验杂志,1998,16(6):333-337. 被引量:13
  • 3[3]Report of a WHO Expert Committee,Arterial hypertension[R].WHO Technical Report Series,Geneva,1978:628.
  • 4[4]Friedewald WT,Levy RI,Fredrickson DS.Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge[J].Clin Hem,1972,18:499-502.
  • 5王湛,郭洪水.高血压病及其伴冠心病患者血脂、脂蛋白、载脂蛋白分析[J].广东医学,1998,19(1):53-54. 被引量:5
  • 6[7]Austin MA,Brunzell JD,Fitch WL,et al.Inheritance of low density lipoprotein Subclass patterns in familial combined hyperlipidemia[J].Arteriosclerosis ,1990,10:520-530.
  • 7[8]Frossard PM,Obineche EN,Lestringant GG.Association of apolipoprotein B gene marker with essential hypertension[J].Hypertension,1999,33(4):1052-1056.
  • 8[9]Parthasarathy S,Barnett J,Fong LG,et al.High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein[J].Biochim biophys Acta,1990,1044:275-283.
  • 9[10]Khoo JC,Miller E,Mcloughin P,et al.Prevention of low density lipoprotein aggregation by high density lipoprotein or apolipoprotein A-Ⅰ[J].J Lipid Res,1990,31: 645-652.
  • 10[11]Lardinois CK,Neuman SL.The effects of antihypertensive agents on serum lipids and lipoproteins[J].Arch Intern Med,1988,48:1280-1288.

二级参考文献12

  • 1胡爱华.血脂异常对血凝、纤溶、血小板、前列环素和内皮细胞功能的影响[J].中国循环杂志,1995,10(4):249-251. 被引量:11
  • 2王宪衍,金翠燕,钱珠,陈曙霞,张国元.赖诺普利与依那普利治疗高血压病的对比研究[J].中华心血管病杂志,1996,24(4):269-271. 被引量:11
  • 3[1] Lancaster SG,Todd PA.Lisinopril:A preliminary review of its pharmacodynamic and pharmacokinetic properties,and therapeutic use in hypertension and congestive heart failure[J].Drugs,1988,35(6):646-669.
  • 4[2] Neutel JM,Frishman WH,Oparil S,et al.Comparison of tel-misartan with linsinopril in patients with mild-to-moderate hypertension[J].Am J Ther,1999,6(3):161-166.
  • 5[5] Charysant-SG.The linsinopril-hydrochlorothiazide group.Antihypertensive effectiveness of low dose linsinopril-hydrochlorothiazide combination[J].Arch Intern Med,1994,154:737-743.
  • 6王抒,中华医学检验杂志,1996年,19卷,339页
  • 7庄一义,临床检验杂志,1997年,15卷,135页
  • 8王抒,中华医学检验杂志,1996年,19卷,343页
  • 9杨国昌,临床检验杂志,1995年,13卷,287页
  • 10Froblich ED.Potential mechanisms explaining the risk of left ventricular hypertrophy .Am J Caidiol,1987,59:91A.

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部